42 related articles for article (PubMed ID: 38561062)
21. Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions.
Thastrup M; Duguid A; Mirian C; Schmiegelow K; Halsey C
Leukemia; 2022 Dec; 36(12):2751-2768. PubMed ID: 36266325
[TBL] [Abstract][Full Text] [Related]
22. Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy.
Wang J; Hu Y; Huang H
J Leukoc Biol; 2017 Dec; 102(6):1347-1356. PubMed ID: 29018147
[TBL] [Abstract][Full Text] [Related]
23. In vitro simulation of the acute lymphoblastic leukemia niche: a critical view on the optimal approximation for drug testing.
Pottosin I; Olivas-Aguirre M; Dobrovinskaya O
J Leukoc Biol; 2023 Jul; 114(1):21-41. PubMed ID: 37039524
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
25. [Research progress on mechanism of bone marrow relapse in pediatric acute lymphoblastic leukemia].
Jiao Y; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):231-5. PubMed ID: 23484726
[TBL] [Abstract][Full Text] [Related]
26. Clinical Analysis of Pediatric T-Cell Acute Lymphoblastic Leukemia Using the MRD-Oriented Strategy System.
Xue YJ; Wang Y; Lu AD; Jia YP; Zuo YX; Ding MM; Zeng HM; Zhang LP
Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):477-483. PubMed ID: 37080879
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.
Jiménez-Morales S; Aranda-Uribe IS; Pérez-Amado CJ; Ramírez-Bello J; Hidalgo-Miranda A
Front Immunol; 2021; 12():737340. PubMed ID: 34867958
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.
Gaudichon J; Jakobczyk H; Debaize L; Cousin E; Galibert MD; Troadec MB; Gandemer V
Blood Rev; 2019 Jul; 36():40-56. PubMed ID: 31010660
[TBL] [Abstract][Full Text] [Related]
29. Chemotactic Cues for NOTCH1-Dependent Leukemia.
Piovan E; Tosello V; Amadori A; Zanovello P
Front Immunol; 2018; 9():633. PubMed ID: 29666622
[TBL] [Abstract][Full Text] [Related]
30. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
31. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.
Gao L; Lu J; Li J; Hu Y; Lu Y; Du W; Hu S
Int J Hematol; 2023 May; 117(5):781-785. PubMed ID: 36472792
[TBL] [Abstract][Full Text] [Related]
32. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
Vadillo E; Dorantes-Acosta E; Pelayo R; Schnoor M
Blood Rev; 2018 Jan; 32(1):36-51. PubMed ID: 28830639
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives.
Lv M; Liu Y; Liu W; Xing Y; Zhang S
Front Immunol; 2022; 13():921894. PubMed ID: 35769486
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?
Nwabo Kamdje AH; Krampera M
Blood; 2011 Dec; 118(25):6506-14. PubMed ID: 21979940
[TBL] [Abstract][Full Text] [Related]
35. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
36. Novel biological insights in T-cell acute lymphoblastic leukemia.
Durinck K; Goossens S; Peirs S; Wallaert A; Van Loocke W; Matthijssens F; Pieters T; Milani G; Lammens T; Rondou P; Van Roy N; De Moerloose B; Benoit Y; Haigh J; Speleman F; Poppe B; Van Vlierberghe P
Exp Hematol; 2015 Aug; 43(8):625-39. PubMed ID: 26123366
[TBL] [Abstract][Full Text] [Related]
37. Thymus-Brain Connections in T-Cell Acute Lymphoblastic Leukemia.
Mendes-da-Cruz DA; Belorio EP; Cotta-de-Almeida V
Neuroimmunomodulation; 2024; 31(1):51-61. PubMed ID: 38272012
[TBL] [Abstract][Full Text] [Related]
38. The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F
Exp Cell Res; 2024 Apr; 437(2):114015. PubMed ID: 38561062
[TBL] [Abstract][Full Text] [Related]
39. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Dander E; Palmi C; D'Amico G; Cazzaniga G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922612
[TBL] [Abstract][Full Text] [Related]
40. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
